Close

Articles

Speed, Quality and Cost – Leveraging Australia to Expedite Clinical Development

In recent years, the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market: being under increasing pressure to expedite the development of new therapies,to decrease clinical study duration, and to...

Capitalizing on Digital Innovation to Enhance Delivery

The 3 Ways Johnson & Johnson Is Capitalizing on Digital Innovation to Better Deliver Medicine to You? Janssen Supply Chain Vice President Remo Colarusso explains how the company is pioneering high-tech new strategies to perfect an age-old mandate: better anticipating...

How implementing electronic clinical outcome assessments (eCOA) into Oncology Clinical Trials Reduces the Burden of Data Collection

Clinical oncology research is unique when compared to other therapeutic areas. Cancer patients experience substantial physical and psychosocial consequences of the disease and its treatment and much of the symptom burden occurs outside the clinical environment. Oncology research is uniquely...

Predicting the future of cancer immunotherapy: Using autoantibody biomarkers to drive safer and more effective treatments

For a number of years now, immunotherapy has been seen as the dawn of a new era, and is the most promising approach to cancer treatment since the use of targeted therapies, making headlines as results for successive novel...

The Pharmacist Perspective: Medication Adherence & Compliance

Adherence generally refers to taking a medication as prescribed which includes maintaining the proper dosing schedule throughout the medication cycle as well as continuing to take a medication for as long as the treatment is necessary. Not only is adherence...

Three Important Factors for Selecting a Reliable Serialization Software

The WHO estimates that roughly 10% of drugs in the global marketplace are counterfeit, with levels being much higher in developing countries (30-40%). In the U.S. alone, the FDA found that more than 50% of online drug purchases are fake....

DSCSA one-month countdown

From 27 November 2018, the Drug Supply Chain Security Act (DSCSA) will be actively enforced by regulators in the US. Here, leaders from across the pharmaceutical sector discuss the industry’s readiness and what companies should be...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read